{"id":"W2743957775","doi":"10.1111/dme.13450","title":"Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase <scp>III ODYSSEY</scp> clinical trials","year":2017,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Prediabetes; Alirocumab; Medicine; PCSK9; Internal medicine; Type 2 diabetes; Population; Diabetes mellitus; Placebo; Endocrinology; Statin; Evolocumab; Cholesterol; Gastroenterology; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01244364,0.0003901458,0.004822687,0.0005152873,0.0001337135,0.00001225487,0.0002607577,0.0002394068,0.0001747921],"category_scores_gemma":[0.01181257,0.0002284435,0.0003840298,0.0007779915,0.0008246858,0.00008576879,0.0001176355,0.0003637397,0.000002114595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006871949,"about_ca_system_score_gemma":0.0003749951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007292182,"about_ca_topic_score_gemma":0.0005188981,"domain_scores_codex":[0.9947167,0.0008312446,0.002127215,0.0006936958,0.001126464,0.0005046575],"domain_scores_gemma":[0.992665,0.003002114,0.001449731,0.001896537,0.0004156569,0.0005709496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01737913,0.002584337,0.8629517,0.002377401,0.01788427,0.0001986101,0.00338433,0.00007249867,0.004025413,0.00006118709,0.001363402,0.08771775],"study_design_scores_gemma":[0.1066944,0.008591332,0.8465046,0.002656919,0.02691585,0.00002188301,0.0005499571,0.002719364,0.003935525,0.000008635926,0.001222257,0.0001792557],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930164,0.003034096,0.0004046052,0.000869458,0.00007791152,0.001899754,0.00006283785,0.00002499274,0.0006098932],"genre_scores_gemma":[0.9967538,0.001422677,0.0005124155,0.0002205946,0.0003611004,0.00007423091,0.0002158633,0.00004329276,0.0003960338],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08931529,"threshold_uncertainty_score":0.9965113,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03817322012029548,"score_gpt":0.3683208319892581,"score_spread":0.3301476118689627,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}